Lovisa Afzelius, Flagship Origination Partner and Co-founder & CEO of Apriori Bio explains how Octavia™, the company’s biology-informed AI engine, enables the design of variant-proof vaccines and how the company is redefining vaccinology. More from Flagship @ JPM2024 here.
Related Companies
- Apriori Bio Founded: 2020
